Skip to main content
. Author manuscript; available in PMC: 2013 Mar 18.
Published in final edited form as: Antivir Ther. 2011 Nov 18;17(2):313–320. doi: 10.3851/IMP1985

Figure 1. Frequency of the HIV-1 antiretroviral drug resistance mutations associated with NRTIsa resistance in the 83CIPRA-SAb participants experiencing viral failure onARV therapy in South Africa.

Figure 1

aNRTI = nucleoside reverse transcriptase inhibitor

bCIPRA-SA is the Comprehensive International Program of Research on AIDS-South Africa.